Psych CASC / OSCE · General adult psychiatry — mood disorders
Explain melancholic vs atypical depression and treatment choices — CASC communication station
MRCPsych/FRANZCP-style communication station: explain melancholic vs atypical feature specifiers, treatment intensity differences, ECT thresholds, MAOI safety concept, and safety-netting.
On this page
Study tools
Target exams
FRANZCPMRCPsychABPNMD-DNB
Prompt
A 38-year-old patient with recurrent depression and their partner ask why the registrar keeps saying 'melancholic features' and why a friend with 'atypical depression' was offered different options, including discussion of an older MAOI medicine. They want plain-language criteria, why ECT was mentioned for severe non-eating depression, what mood reactivity means, suicide-risk honesty, and bipolar screening rationale.
Station brief
Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in a secondary-care mood clinic. [4]
Candidate instructions. Explain melancholic versus atypical feature labels in plain language, why treatment intensity can differ, when ECT is discussed, what an MAOI pathway would involve if ever considered, why bipolar screening matters, and how to seek help if risk rises. Check understanding with teach-back. [4][6]
References6ShowHide
- [1]Liebowitz MR, et al. Antidepressant specificity in atypical depression Arch Gen Psychiatry, 1988.PMID 3276282
- [2]Jarrett RB, et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial Arch Gen Psychiatry, 1999.PMID 10232298
- [3]UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis Lancet, 2003.PMID 12642045
- [4]Malhi GS, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Aust N Z J Psychiatry, 2021.PMID 33353391
- [5]Van den Eynde V, et al. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr, 2023.PMID 35837681
- [6]Stewart JW Treating depression with atypical features J Clin Psychiatry, 2007.PMID 17348764